ALDH3A1 and non-small cell lung carcinoma: To evaluate the possible effects of inhibiting ALDH1A1, ALDH1A3, and ALDH3A1 isoenzymes, we used 14 NSCLC cell lines with different oncogenic driver alterations and the noncancerous cell line BEAS-2B for comparison.